The Influence of Hormonal Changes During Pregnancy on Corneal Biomechanics in Humans

Sponsor
University Hospital, Geneva (Other)
Overall Status
Completed
CT.gov ID
NCT01629264
Collaborator
(none)
50
1
24
2.1

Study Details

Study Description

Brief Summary

The intraocular pressure in the human bulbus requires that the "wall" of the eye shows a certain (bio)mechanical strength. The human cornea represents the anterior portion of this wall. Since several years, there is a growing interest in the ophthalmological community for identifying factors modulating the biomechanical stability of the human cornea. Reasons are twofold: advances in keratoconus research and the increasing numbers of refractive laser surgery procedures with (correspondingly) increasing numbers of complications due to non-respecting the limits of corneal biomechanics.

There is evidence that oestrogen, but also thyroïd hormone changes have a major impact on corneal biomechanics. A number of recent observational studies have reported on keratoconus and refractive laser surgery patients with decompensating biomechanics during pregnancy.

Both hormones also show physiological changes during pregnancy and little is known about the impact of these physiological changes on the human cornea.

The aim of this study is to establish baseline values for physiological changes in the human cornea during pregnancy.

Condition or Disease Intervention/Treatment Phase
  • Device: Ocular Response Analyzer
  • Device: Scheimpflug measurement
  • Other: Blood sample

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Influence of Pregnancy-related Hormonal Fluctuations on Corneal Biomechanics in Humans
Study Start Date :
Jun 1, 2012
Actual Primary Completion Date :
Jun 1, 2014
Actual Study Completion Date :
Jun 1, 2014

Outcome Measures

Primary Outcome Measures

  1. Correlate oestradiol and TSH plasma changes with changes in corneal CRF and CH and topographical changes [15 months]

    3 examinations during pregnancy (gestation week 10-14, 20-26, and 36-40) and one visit at 6 months after pregnancy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Older than 18 years

  • Pregnancy confirmed by echography

  • Before gestation week 14

Exclusion Criteria:
  • Pre-existing corneal disease

  • Previous eye surgery

  • Inability to understand the nature of the study

  • Patient with legal guardian

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Geneva Geneva GE Switzerland 1211

Sponsors and Collaborators

  • University Hospital, Geneva

Investigators

  • Principal Investigator: Farhad Hafezi, MDPhD, University Hospital, Geneva

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Farhad Hafezi, Professor and Chairman of Ophthalmology, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT01629264
Other Study ID Numbers:
  • CER-11-180
  • GE-OPHT-2012-1
First Posted:
Jun 27, 2012
Last Update Posted:
Mar 16, 2016
Last Verified:
Mar 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Farhad Hafezi, Professor and Chairman of Ophthalmology, University Hospital, Geneva

Study Results

No Results Posted as of Mar 16, 2016